CONSERVED CORONAVIRUS T CELL EPITOPES
Espacenet
Family 78806432
Abstract
The invention relates to a T cell antigen and/or T cell polyantigen comprising one or more conserved coronavirus T cell epitopes, to a nucleic acid molecule encoding said T cell antigen and/or T cell polyantigen, and to a T-cell receptor (TCR) that specifically recognizes a conserved coronavirus T cell epitope. The invention further relates to a pharmaceutical composition comprising said protein, TCR or nucleic acid molecule, and to the use thereof in a method of inducing an immune response in an individual.
Inventors 4
- Camps, Marcelle Gerardus Mathijs
- Jeroen van Bergen Aachen author as filed: van Bergen, Jeroen
- Ossendorp, Ferdinand Antonius
- Gerben C. M. Zondag Aachen author as filed: Zondag, Gerben Carolus Martinus
Inventors are linked to an Aachen author when surname and first name match exactly one author.
Applicants
- SYNVOLUX IP B.V.
- ACADEMISCH ZIEKENHUIS LEIDEN H.O.D.N. LUMC GBS Leiden
- Synvolux Ip Bv
Cited papers 3 in the database
Non-patent literature as cited (58)
- - SOLINGER ET AL., J EXP MED, vol. 150, 1979, pages 830 - 48
- - ZIRLIC ET AL., BLOOD, vol. 108, 2006, pages 3865 - 3870
- - CALIS ET AL., PLOS COMPUT BIOL, vol. 9, 2013, pages 1003266
- - SAETHANG ET AL., J IMMUNOL METHODS, vol. 387, 2013, pages 293 - 302
- - JORGENSEN ET AL., IMMUNOLOGY, vol. 141, 2014, pages 18 - 26
- - RASMUSSEN ET AL., J IMMUNOL, vol. 197, 2016, pages 1517 - 24
- - TROLLENIELSEN, IMMUNOGENETICS, vol. 66, 2014, pages 449 - 56
- - KAROSIENE ET AL., IMMUNOGENETICS, vol. 64, 2012, pages 177 - 86
- - JURTZ ET AL., BIORXIV, 2018
- - NIELSEN ET AL., PROTEIN SCI, vol. 12, 2003, pages 1007 - 17
- - ANDREATTANIELSEN, BIOINFORMATICS, vol. 32, 2016, pages 511 - 7
- - RAMMENSEE ET AL., IMMUNOGENETICS, vol. 50, 1999, pages 213 - 9
- - FLERI ET AL., FRONT IMMUNOL, 2017
- - BAGAEV ET AL., NUCLEIC ACIDS RES, vol. 48, 2020
- - TICKOTSKY ET AL., BIOINFORMATICS, vol. 33, 2017, pages 2924 - 9
- - BORRMAN ET AL., STRUCT FUNCT BIOINF, vol. 85, 2017, pages 908 - 16
- - LEEM ET AL., NUCLEIC ACIDS RES, vol. 46, 2018
- - REYNISSON ET AL., BIORXIV, 2019
- - BUI ET AL., IMMUNOGENETICS, vol. 57, 2005, pages 304 - 314
- - NIELSEN ET AL., BMC BIOINFORMATICS, vol. 8, 2007, pages 238
- - DOYTCHINOVA ET AL., J IMMUNOL, vol. 172, 2004, pages 4314 - 23
- - LUND ET AL., IMMUNOGENETICS, vol. 55, 2004, pages 797 - 810
- - DOYTCHINOVA ET AL., J IMMUNOL, vol. 174, 2005, pages 7085 - 95
- - SIDNEY ET AL., BMC IMMUNOL, vol. 9, 2008, pages 1
- - OSEN ET AL., VACCINE, vol. 19, 2001, pages 4276 - 86
- - OOSTERHUIS ET AL., INT J CANCER, vol. 129, 2011, pages 397 - 406
- - BRENDA ET AL., J INFECTIOUS DISEASES, vol. 181, 2000, pages 1001 - 1009
- - XU ET AL., ISCIENCE, vol. 23, 2020, pages 101399
- - ALEXANDER ET AL., IMMUNITY, vol. 1, 1994, pages 751 - 761
- - MERRIFIELD, J AM CHEM SOC, vol. 85, 1963, pages 2149 - 2156
- - ATHERTON ET AL.: "Solid Phase Peptide Synthesis", 1989, IRL PRESS
- - BERTHOLDWALTER, BIOLOGICALS, vol. 22, 1994, pages 135 - 150
- - ANTOINE ET AL., VIROLOGY, vol. 244, 1998, pages 365 - 96
- - FALKNERHOLZER, CURR GENE THER, vol. 4, 2004, pages 417 - 26
- - CARUTHERS, SCIENCE, vol. 230, 1985, pages 281 - 285
- - BRITO ET AL., ADV GENET, vol. 89, 2015, pages 179 - 233
- - STEPINSKI ET AL., RNA, vol. 7, 2001, pages 1486 - 1495
- - ROSSSULLIVAN, BLOOD, vol. 66, 1985, pages 1149 - 1154
- - KARIKO ET AL., MOL THER, vol. 16, 2008, pages 1833 - 1840
- - KARIKO ET AL., IMMUNITY, vol. 23, 2005, pages 165 - 175
- - GALLIE, GENES DEV, vol. 5, 1991, pages 2108 - 2116
- - PARDI ET AL., NATURE REVIEWS, vol. 17, 2018, pages 261 - 279
- - MCCRAY ET AL., J VIROL, vol. 81, 2007, pages 813 - 821
- - ARENS ET AL., J IMMUNOL, vol. 86, 2011, pages 3874 - 3881
- - WINZLER ET AL., J EXP MED, vol. 185, 1997, pages 317 - 328
- - SHOLUKH ET AL., MEDRXIV, 2020
- - "GenBank", Database accession no. NC 045512
- - ZHI ET AL., VIROLOGY, vol. 335, 2005, pages 34 - 45
- - HUANG ET AL., VACCINE, vol. 25, 2007, pages 6981 - 6991
- - ZHAO ET AL., J VIROL, vol. 84, 2010, pages 9318 - 9325
- - POH ET AL., J MED VIROL, vol. 81, 2009, pages 1131 - 1139
- - CHANNAPPANAVAR ET AL., J VIROL, vol. 88, 2014, pages 11034 - 11044
- - DANGI ET AL., BIORXIV, 2021, Retrieved from the Internet <URL:https://doi.org/10.1101/2021.06.01.446491>
- - ALMOFTI YASSIR A. ET AL: "Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)", BMC IMMUNOLOGY, vol. 22, no. 1, 25 March 2021 (2021-03-25), XP055944092, Retrieved from the Internet <URL:https://bmcimmunol.biomedcentral.com/track/pdf/10.1186/s12865-021-00412-0.pdf> DOI: 10.1186/s12865-021-00412-0
- - CAN HÜSEYIN ET AL: "In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19", SCIENTIFIC REPORTS, 28 December 2020 (2020-12-28), England, pages 22387 - 22387, XP055944098, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769971/pdf/41598_2020_Article_79645.pdf> [retrieved on 20220719], DOI: 10.1038/s41598-020-79645-9
- - STEPHEN N. CROOKE ET AL: "Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome", SCIENTIFIC REPORTS, vol. 10, no. 1, 25 August 2020 (2020-08-25), XP055770118, DOI: 10.1038/s41598-020-70864-8
- - VIANA INVENÇÃO MARIA DA CONCEIÇÃO ET AL: "Development of synthetic antigen vaccines for COVID-19", HUMAN VACCINES & IMMUNOTHERAPEUTICS, vol. 17, no. 11, 2 November 2021 (2021-11-02), US, pages 3855 - 3870, XP055918454, ISSN: 2164-5515, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506811/pdf/KHVI_17_1974288.pdf> DOI: 10.1080/21645515.2021.1974288
- - MOISE L ET AL: "VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 29, no. 3, 10 January 2011 (2011-01-10), pages 501 - 511, XP027575654, ISSN: 0264-410X, [retrieved on 20101104]